Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230

Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever

(2018) So Jung An et al.   VACCINE

Outer membrane vesicles for vaccination and targeted drug delivery

(2018) Sihan Wang et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines

(2018) Vinay Menon et al.   Frontiers in Immunology

Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission

(2018) Gaspar E. Canepa et al.   npj Vaccines

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults

(2018) Issaka Sagara et al.   LANCET INFECTIOUS DISEASES

Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults

(2018) Jessica A. Chichester et al.   VACCINE

Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine

(2017) Michael Theisen et al.   Expert Review of Vaccines

Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine

(2017) Susheel K. Singh et al.   Microbial Cell Factories

Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity

(2017) Puthupparampil V. Scaria et al.   PLoS One

Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display

(2017) Susheel K. Singh et al.   VACCINE

Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation

(2017) Dibyadyuti Datta et al.   VACCINE

Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate

(2017) Andrea J. Radtke et al.   Scientific Reports

Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of thePlasmodium falciparumSexual Stage Protein Pfs230

(2016) Nicholas J. MacDonald et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Method for Producing Protein Nanoparticles with Applications in Vaccines

(2016) David S. Jones et al.   PLoS One

Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine

(2016) Donald J. Chabot et al.   VACCINE

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults

(2016) Kawsar R. Talaat et al.   PLoS One

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology

(2016) Yuanyuan Li et al.   Scientific Reports

Outer membrane vesicles as platform vaccine technology

(2015) Leo van der Pol et al.   Biotechnology Journal

Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles

(2015) Rajesh Kumar et al.   VACCINE

Recent advances in recombinant protein-based malaria vaccines

(2015) Simon J. Draper et al.   VACCINE

Outer membrane vesicles as platform vaccine technology

(2015) Leo van der Pol et al.   Biotechnology Journal

A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program

(2013) Miguel O’Ryan et al.   DRUGS

A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice

(2013) R. Mark Jones et al.   PLoS One

The Human Malaria Parasite Pfs47 Gene Mediates Evasion of the Mosquito Immune System

(2013) A. Molina-Cruz et al.   SCIENCE

Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle

(2013) Richard L. Shimp et al.   VACCINE

Expression, Immunogenicity, Histopathology, and Potency of a Mosquito-Based Malaria Transmission-Blocking Recombinant Vaccine

(2012) D. K. Mathias et al.   INFECTION AND IMMUNITY

Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex

(2012) Craig Przysiecki et al.   Frontiers in Cellular and Infection Microbiology

Outer Membrane Protein Complex of Meningococcus Enhances the Antipolysaccharide Antibody Response to Pneumococcal Polysaccharide–CRM197Conjugate Vaccine

(2011) Zengzu Lai et al.   Clinical and Vaccine Immunology

N-Terminal Prodomain of Pfs230 Synthesized Using a Cell-Free System Is Sufficient To Induce Complement-Dependent Malaria Transmission-Blocking Activity

(2011) Mayumi Tachibana et al.   Clinical and Vaccine Immunology

A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum

(2011) Christine E. Farrance et al.   Clinical and Vaccine Immunology

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

(2009) Johan Holst et al.   VACCINE

Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedure

(2008) Feng Qian et al.   MICROBES AND INFECTION

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

(2008) Yimin Wu et al.   PLoS One